Our results could suggest that the FGFR4 signaling pathway might be the distinct molecular subgroup that could stratify iCCA patients based on their prognosis; however, the reasons for the association between this genetic aberration and a better prognosis is unexplained in this study. This evidence concerns the gene FGFR4 and infantile convulsions and choreoathetosis.